Home Smith & Nephew Completes $50 Million Acquisition of Ceterix Orthopaedics and Its NovoStitch Pro Meniscal Repair System

Smith & Nephew Completes $50 Million Acquisition of Ceterix Orthopaedics and Its NovoStitch Pro Meniscal Repair System

Jan 24, 2019 09:31 CST Updated 09:31

VCBeat (WeChat: vcbeat) has learned that Smith & Nephew recently announced the completion of its acquisition of Ceterix Orthopaedics and its meniscus repair system, NovoStitch Pro. Smith & Nephew had agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device in late 2018, and the transaction has now been formally closed for $50 million. Smith & Nephew stated that, based on projected financial performance, the deal is expected to generate an additional $55 million in revenue.

 

Smith & Nephew is a global medical technology company that serves healthcare professionals in more than 100 countries, helping them improve patients’ health outcomes. Smith & Nephew adopts pioneering approaches to designing advanced medical products and services, ensuring broader access to a diverse portfolio of technologies for customers worldwide and delivering better outcomes for patients and healthcare systems. In addition, the company offers a range of medical devices, personal care products, and both conventional and innovative wound care therapies.


微信图片_20190124092538_副本.png 

(Image source: Ceterix Orthopaedics official website)


To date, Smith & Nephew has completed 17 acquisitions. The most recent occurred in December 2017, when the company acquired Rotation Medical, a firm dedicated to the treatment of rotator cuff disorders, for $210 million. (The rotator cuff is a collective term for the tendon tissues of the subscapularis, supraspinatus, infraspinatus, and teres minor muscles, which cover the anterior, superior, and posterior aspects of the shoulder joint. It is located beneath the acromion and deltoid muscle and is closely connected to the joint capsule.)

 

According to statistics, more than 1.2 million patients with meniscal tears undergo surgical treatment in the United States each year, among whom only 15%–20% receive meniscus repair rather than meniscectomy. Smith & Nephew has stated that, leveraging the advantages of products such as NovoStitch Pro and FAST-FIX 360, this proportion has the potential to double.

 

Meniscal Tear: A Rupture of the Crescent-Shaped Fibrocartilage Within the Knee JointA meniscal tear refers to a rupture of the crescent-shaped fibrocartilage located within the knee joint. Such tears are primarily caused by torsional forces applied when the knee is in a semi-flexed or fully flexed position. They are commonly seen in soccer-related injuries and among individuals who frequently work in a squatting position, such as coal miners. Medial meniscal tears are more common than lateral meniscal tears, which is attributable to the anatomical characteristics of the menisci. Meniscal tears can be classified as either chronic degenerative tears or acute traumatic tears.

 

NovoStitch Pro addresses complex meniscal tears that other repair systems cannot manage. It enables surgeons to repair horizontal, radial, complex, bucket-handle, root, and vertical tears under arthroscopy. This system serves as a strong complement to Smith & Nephew’s leading 360° Meniscal Fast-Fix Repair System.

 

Regarding this transaction, Brad Cannon, President of the Medical and ENT Division at Smith & Nephew, stated: “NovoStitch Pro is an outstanding technology that addresses unmet clinical needs. We are delighted to add this device to our sports medicine portfolio and look forward to the greater opportunities it will bring us in the near future.”

 

Ceterix Orthopaedics was founded in October 2010 and is headquartered in Menlo Park, California, USA. The company was established based on the inventions of Justin Saliman, an orthopedic surgeon specializing in sports medicine. Dr. Saliman envisioned improving the outcomes of arthroscopic surgery by enabling surgeons to place suture patterns that are currently only achievable through open surgery.

 

Ceterix Orthopaedics, an orthopedic company dedicated to the research and development of novel surgical instruments, leverages its precision technology to enable surgeons to perform suturing within confined joint spaces while safeguarding sensitive surrounding structures, such as nerves, arteries, and cartilage.